Everence Capital Management Inc. Takes Position in HealthEquity, Inc. (NASDAQ:HQY)

Everence Capital Management Inc. purchased a new position in shares of HealthEquity, Inc. (NASDAQ:HQY) during the fourth quarter, HoldingsChannel reports. The firm purchased 2,430 shares of the company’s stock, valued at approximately $233,000.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Wasatch Advisors LP increased its position in shares of HealthEquity by 6.6% during the third quarter. Wasatch Advisors LP now owns 7,758,890 shares of the company’s stock worth $635,065,000 after acquiring an additional 483,269 shares in the last quarter. Mackenzie Financial Corp increased its holdings in HealthEquity by 16.0% during the 2nd quarter. Mackenzie Financial Corp now owns 2,364,521 shares of the company’s stock worth $203,822,000 after purchasing an additional 325,906 shares in the last quarter. Vaughan Nelson Investment Management L.P. increased its holdings in HealthEquity by 36.7% during the 3rd quarter. Vaughan Nelson Investment Management L.P. now owns 843,423 shares of the company’s stock worth $69,034,000 after purchasing an additional 226,563 shares in the last quarter. Thrivent Financial for Lutherans raised its stake in shares of HealthEquity by 924.2% in the second quarter. Thrivent Financial for Lutherans now owns 220,220 shares of the company’s stock worth $18,983,000 after purchasing an additional 198,718 shares during the last quarter. Finally, Dimensional Fund Advisors LP lifted its holdings in shares of HealthEquity by 8.1% in the second quarter. Dimensional Fund Advisors LP now owns 1,547,402 shares of the company’s stock valued at $133,377,000 after purchasing an additional 115,841 shares in the last quarter. Institutional investors own 99.55% of the company’s stock.

Insider Transactions at HealthEquity

In other HealthEquity news, Director Stuart B. Parker sold 25,000 shares of the company’s stock in a transaction dated Thursday, December 12th. The shares were sold at an average price of $96.72, for a total transaction of $2,418,000.00. Following the sale, the director now directly owns 19,061 shares of the company’s stock, valued at $1,843,579.92. This represents a 56.74 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Frank Corvino sold 1,039 shares of HealthEquity stock in a transaction dated Wednesday, November 6th. The stock was sold at an average price of $96.10, for a total transaction of $99,847.90. Following the completion of the transaction, the director now owns 3,784 shares of the company’s stock, valued at $363,642.40. The trade was a 21.54 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 34,289 shares of company stock worth $3,355,718. 2.20% of the stock is owned by company insiders.

HealthEquity Price Performance

Shares of NASDAQ HQY opened at $99.74 on Thursday. The company has a current ratio of 3.20, a quick ratio of 4.10 and a debt-to-equity ratio of 0.51. The stock has a fifty day simple moving average of $97.57 and a two-hundred day simple moving average of $85.79. HealthEquity, Inc. has a 1-year low of $65.01 and a 1-year high of $105.82. The firm has a market cap of $8.64 billion, a price-to-earnings ratio of 91.50, a price-to-earnings-growth ratio of 1.08 and a beta of 0.54.

Analyst Ratings Changes

HQY has been the subject of several recent research reports. Royal Bank of Canada upped their price target on HealthEquity from $100.00 to $105.00 and gave the stock an “outperform” rating in a report on Tuesday, December 10th. Barrington Research increased their target price on shares of HealthEquity from $105.00 to $120.00 and gave the company an “outperform” rating in a report on Monday, December 2nd. Mizuho assumed coverage on shares of HealthEquity in a report on Wednesday, December 4th. They set an “outperform” rating and a $126.00 price target on the stock. BTIG Research increased their price objective on shares of HealthEquity from $110.00 to $130.00 and gave the company a “buy” rating in a research note on Thursday, November 14th. Finally, Bank of America lifted their target price on shares of HealthEquity from $100.00 to $120.00 and gave the stock a “buy” rating in a research report on Wednesday, November 13th. One analyst has rated the stock with a hold rating and thirteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $110.71.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.